Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism IRE1 inhibitors(Serine/threonine-protein kinase/endoribonuclease IRE1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus | Preclinical | United States | ![]() | - |
Idiopathic Pulmonary Fibrosis | Preclinical | United States | ![]() | - |
Retinitis Pigmentosa | Preclinical | United States | ![]() | - |
Motor Neuron Disease | Discovery | United States | ![]() | - |
Neoplasms | Discovery | United States | ![]() | - |
Nonalcoholic Steatohepatitis | Discovery | United States | ![]() | - |